about
Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesisDihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathwayCordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation.Alliin Attenuated RANKL-Induced Osteoclastogenesis by Scavenging Reactive Oxygen Species through Inhibiting Nox1Cordycepin inhibits chondrocyte hypertrophy of mesenchymal stem cells through PI3K/Bapx1 and Notch signaling pathway.Role of cadherin-11 in synovial joint formation and rheumatoid arthritis pathology.DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis.MicroRNAs in Bone Balance and Osteoporosis.Staphylococcal lipoteichoic acid promotes osteogenic differentiation of mouse mesenchymal stem cells by increasing autophagic activity.HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis.Staphylococcal protein A promotes osteoclastogenesis through MAPK signaling during bone infection.Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.Cerium Oxide Nanoparticle Modified Scaffold Interface Enhances Vascularization of Bone Grafts by Activating Calcium Channel of Mesenchymal Stem Cells.Alendronate induces osteoclast precursor apoptosis via peroxisomal dysfunction mediated ER stress.MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.Effect of microRNA-145 on IL-1β-induced cartilage degradation in human chondrocytes.Physalin D regulates macrophage M1/M2 polarization via the STAT1/6 pathwayIL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesisDual Effect of Cyanidin on RANKL-Induced Differentiation and Fusion of OsteoclastsNon-coenzyme role of vitamin B1 in RANKL-induced osteoclastogenesis and ovariectomy induced osteoporosisThe role of physical forces in osteoclastogenesisLncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signalingDendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis
P50
Q36560200-9F7EDC5A-6292-4B73-862A-351E70325EE6Q36775054-0A166DE5-37AB-41CC-907F-7A0085F3A159Q36846350-E12E8FF4-EC55-47D7-823A-D0CC4382D359Q37286542-EB2902B1-2E36-4761-A19A-EE8650E893B4Q37581283-AD930856-1237-432C-818B-DC0CAEBE5238Q38067330-22F9A7E4-0F96-4665-9B82-9DC07A76902AQ38178193-CAEC9E23-BF3C-4E27-8723-7AFA4E5F6399Q38556136-C11E2790-ECDC-463F-83E5-BD9649CEC5FBQ38715737-F70325D3-10A1-427A-9AAD-9CCC29B77005Q39932979-4A9B8268-09AA-4CFA-97E8-E7207DDBE392Q40337871-F8DAD516-51ED-49AB-AA4A-51E72C4489A6Q46605120-62582C01-4BF9-49C1-A0D9-8D2F69C1D2DAQ50885743-37C3E006-FFC6-4F54-A233-16E2507B8653Q52619872-4381A5B6-23AF-4D66-8E7E-D6DB450A268CQ53473415-4C3EDD5F-AF26-4FD7-9F03-48A4FDCBBE4DQ53539498-A6F5D0EC-8FB4-4CD2-AE77-DAA2B63EF96DQ57467126-D105E77F-42EF-43BB-8865-F622D2284DDFQ64078002-515765A2-D3B9-44D1-AC3F-AE2205B1A3CAQ86419329-7FA77068-40BD-4B08-82C9-B244E2144C5BQ89890255-8C5FC66C-6EB9-4F4B-910A-325C6229C372Q90955026-3F3A8831-BE9D-4A07-87B1-7DC7350C6763Q91075503-0491819A-4799-455C-AD2F-27B7AF74AB1AQ92546322-B8977BB6-CA24-45EE-875C-D8BEF26E51AEQ96127116-2D6ED90E-0DB1-4A99-8CFC-AC73ABEE90DE
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6983-6354
@en
name
Ce Dou
@ast
Ce Dou
@en
Ce Dou
@es
Ce Dou
@nl
type
label
Ce Dou
@ast
Ce Dou
@en
Ce Dou
@es
Ce Dou
@nl
prefLabel
Ce Dou
@ast
Ce Dou
@en
Ce Dou
@es
Ce Dou
@nl
P106
P1153
55514939800
P31
P496
0000-0002-6983-6354